Boston Scientific ((BSX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Zacks Investment Research on MSN
BSX's Neuromodulation Prospect Looks Strong: What's Behind It?
The rising incidences of chronic pain, neurological disorders and mental health conditions continue to drive the demand for global neuromodulation devices. According to Grand View Research, the market ...
The FDA approved Boston Scientific Corp.’s Vercise Deep Brain Stimulation System to treat the symptoms of Parkinson’s disease. Boston Scientific’s system works by stimulating a region of the brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback